Detalhe da pesquisa
1.
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemic.
Immunity;
55(10): 1764-1778, 2022 10 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36049482
2.
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.
Nature;
601(7891): 110-117, 2022 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34758478
3.
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
Nature;
584(7821): 457-462, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32668444
4.
Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming.
Nature;
574(7777): 200-205, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31582858
5.
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue Localization.
Int J Mol Sci;
23(18)2022 Sep 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36142588
6.
Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.
Gastroenterology;
159(2): 652-664, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32302614
7.
Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
J Hepatol;
72(1): 34-44, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31348999
8.
Use of Expression Profiles of HBV-DNA Integrated Into Genomes of Hepatocellular Carcinoma Cells to Select T Cells for Immunotherapy.
Gastroenterology;
156(6): 1862-1876.e9, 2019 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30711630
9.
Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell-treated patients.
Blood;
140(2): 156-160, 2022 07 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35472242
10.
Quest for immunological biomarkers in the management of CHB patients.
Gut;
72(11): 2012-2014, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36922017
11.
Enolase: a metabolic checkpoint behind diverse exhaustion stages of CD8+ T cells in chronic HBV and HCV.
Gut;
72(10): 1814-1815, 2023 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37673656
12.
Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB'.
J Hepatol;
79(5): e202-e204, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37307998
13.
Advances in NKG2D ligand recognition and responses by NK cells.
Immunol Cell Biol;
92(3): 230-6, 2014 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24445601
14.
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection.
Cell Mol Immunol;
21(2): 159-170, 2024 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38221577
15.
Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop.
Virology;
595: 110089, 2024 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38640789
16.
Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children.
Nat Med;
30(5): 1373-1383, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38689059
17.
BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study.
Sci Rep;
13(1): 17337, 2023 10 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37833554
18.
Engineering immunosuppressive drug-resistant armored (IDRA) SARS-CoV-2 T cells for cell therapy.
Cell Mol Immunol;
20(11): 1300-1312, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37666955
19.
Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults.
J Clin Invest;
133(13)2023 07 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37219944
20.
SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity.
J Exp Med;
219(10)2022 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35972472